SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$1.23
-0.17 (-12.14%)
▼
5d:
+5.13%
30d:
-42.52%
90d:
+13.9%
HOLD
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
3d
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBFM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBFM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.78
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.35
47.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $1.23, which is considered oversold relative to its 30-day fair value range of $1.38 to $2.08. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.0) compared to its historical average (13.5). Remarkably, the market is currently pricing in an annual earnings decline of 19.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.10, while resistance sits at $1.69. Short-term momentum is weak, with the stock down 12.1% recently.
Market Sentiment: SBFM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $56.00 (+3900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.10, while resistance sits at $1.69. Short-term momentum is weak, with the stock down 12.1% recently.
Market Sentiment: SBFM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $56.00 (+3900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.38 -
$2.08
Company Quality Score
47/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-12.1%)
- BULLISH: Trading 3900.0% below Wall St target ($56.00)
Trading Range Analysis
30-Day Trading Range
$1.38 -
$2.08
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.69
Current Trend
Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.00
Wall Street Target
$56.00
(+3900.0%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-17.0%
Valuation Discount vs History
-19.6% cheaper
PE vs Historical
7.0 vs 13.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.6%
(market-implied from PE analysis)
1-Year Target
$1.26
(-10%)
2-Year Target
$1.13
(-19%)
3-Year Target
$1.02
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→14)
$1.97
(+41%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.0 to 13.5
Stabilization Target:
$2.70
(+92.9%)
PE Expansion Potential:
+92.9%
Share & Embed Analysis
Last updated: August 07, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 49 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 46 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 47 HOLD |
